Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 May 17.
Published in final edited form as: J Epidemiol Community Health. 2020 Aug 27;75(1):56–61. doi: 10.1136/jech-2020-214267

Regional Differences in the Impact of Diabetes on Population Health in the United States

Emma Zang 1, Scott M Lynch 2,3,4, Jessica S West 2
PMCID: PMC8128513  NIHMSID: NIHMS1697900  PMID: 32855262

Abstract

Background.

To evaluate regional disparities in the influence of diabetes on population health, we examine life expectancies at age 50 between diabetic and healthy populations and life quality among the diabetic population among native-born Americans by birth region and current residence.

Methods.

Using data on a cohort of 17 686 native-born individuals from the Health and Retirement Survey (1998–2014), we applied a Bayesian multistate life table method to estimate life expectancies at age 50 between diabetic and healthy populations by each birth-current region combination. We further estimate the proportion of life remaining without either chronic conditions or disabilities as a quality of life measure and the probabilities that 1 region is worse than the other in terms of different health outcomes.

Results.

At age 50, persons with diabetes were expected to live on average 5.8–10.8 years less than their healthy equivalents across regions. Diabetes had the greatest influence on life expectancy for older adults who lived in the south at the time of interviews. Persons with diabetes born in the south were more likely to have developed chronic conditions or disabilities and spent greater proportions of life with these 2 issues compared to other regions.

Conclusion.

Diabetes is a significant threat to life expectancy and healthy life expectancy in the U.S., particularly for people born or living in the south.

Keywords: Diabetes, Quality of life, Geography, Epidemiology of chronic diseases, Health expectancy


Diabetes is a major cause of morbidity and mortality in the U.S., and its prevalence has increased rapidly in the overall population over the past few decades driven, in part, by the obesity epidemic.1 In 2015, approximately 9.4% (30.3 million) of Americans had diabetes, with that number nearly tripled (25.2%) for adults aged 65 or older.2 The rise in diabetes may contribute to a decline in future life expectancy (LE).3 While LE at birth in other developed countries has increased, U.S. LE has declined, partly perhaps due to increases in cause-specific mortality caused by drug overdoses, alcohol abuse, suicides, and diseases including hypertensive diseases and diabetes.4 Large disparities exist in LEs between populations with and without diabetes in the U.S.,57 indicating that the long-term rise in the prevalence of diabetes has major implications for longevity and health.

Previous studies primarily report LE by sex and race/ethnicity but neglect the impact of regional differences on health disparities. This omission has public health consequences. For example, establishing patterns of stroke in the American “stroke belt” allowed for further study of disease etiology and the development of targeted interventions.8,9 Diabetes, like stroke, is influenced by cultural, behavioral, and environmental factors interacting with genetic susceptibility, and is geographically patterned: diagnosed diabetes prevalence is lowest in the Midwest and northeast but highest in southern and Appalachian states.10,11 Despite evidence that diabetes is more prevalent in the south, little research considers the joint roles of birth and current regions in LE disparities. Theoretically, birth region provides a proxy for childhood exposures and possibly long-term exposures assuming individuals typically grow up in the region of birth, whereas current region measures current environment. The 2 concepts may combine in contributing to later life health outcomes.

Moreover, it is important to gauge the broader impact of diabetes via a more global measure of population health that considers both morbidity and mortality rather than any single health outcome. One approach is to estimate health expectancy (HE), which entails analyzing both healthy and unhealthy years of life and defines health along numerous dimensions.12 HE monitors population health by measuring both quantity and quality of life-years by adding a quality-of-life (QoL) aspect to LE.12 Since older adults with diabetes often later develop chronic conditions13 and disabilities,14 and persons with diabetes (PWD) with chronic conditions or disabilities typically have greater difficulties in self-care compared to individuals with only diabetes,13 estimating LE without chronic conditions and disability among PWD is important.

The current study examines whether diabetes is equally consequential to health and survival across the U.S. We first examine regional differences in LEs at age 50 between diabetic and healthy populations, considering the joint role of birth and current region. Second, we calculate the proportion of life remaining without either chronic conditions or disabilities (%XLE) among PWD. Finally, we estimate the probabilities that 1 region is worse than the others in terms of different health outcomes. Based on previous research, we hypothesize that: 1) PWD will have shorter LEs compared to their healthy counterparts across all U.S. regions and 2) southern birth and residence will be associated with shorter LE and larger proportions of life spent with chronic conditions or disability for PWD.

METHODS

The Health and Retirement Survey (HRS) is a biennial, nationally representative, longitudinal panel survey of over 30 000 non-institutionalized U.S. adults over age 50.15 We restrict our sample (1998–2014) to individuals interviewed in 1998 or recruited to the survey in 2004 or 2010, individuals aged 50 or older, and to 1 individual per household. We exclude individuals if they: were dropped by the HRS in any later wave, did not live in the U.S. at 1 or more study waves, were foreign born, or were missing health information at the beginning or ending of transition intervals. Our final sample of 16 983 individuals contribute 80 146 person transition intervals (the 2-year period between waves).

Measures

The outcome variables are health transitions between study waves (transition intervals), where transitions are defined by combinations of health statuses at the beginning and end of a transition interval. Three health variables are included in these transitions. Diabetes is a self-reported diabetes diagnosis (no/yes, “Has a doctor ever told you that you have diabetes or high blood sugar?”). Diabetes is associated with a higher risk of chronic conditions including heart disease (heart attack, coronary heart disease, angina, congestive heart failure, or other heart problems), stroke, cancer (cancer or malignant tumor, excluding minor skin cancer), and lung disease (chronic lung disease, i.e. chronic bronchitis or emphysema).1621 Dummy variables indicate whether participants have ever been told by a doctor that they had these conditions. Activities of daily living (ADL) disability is based on whether participants report difficulty with any 1 of the following (no/yes): dressing, bedding, bathing, toileting, walking, or eating.

At the beginning of a transition interval, individuals may (1) be healthy, (2) have diabetes, (3) have at least 1 other chronic condition (heart disease, stroke, cancer, or lung disease), (4) have at least 1 ADL, (5–7) have any 2-way combination of diabetes, other conditions, or ADLs, or (8) have diabetes, at least 1 other chronic condition, and at least 1 ADL. At the end of a transition interval, death is a possible outcome. These 9 possible health statuses represent a 9-by-9 state space for possible transitions across transition intervals. Consistent with previous research,5 we assume some transitions are impossible: once diagnosed with diabetes or another chronic condition, individuals cannot return to a state without such a diagnosis. Figure 1 shows the state space and 44 transitions that are possible over a transition interval. Transition A to DC has only 10 observations and is recoded to transition A to DCA for modelling purposes.

Figure 1:

Figure 1:

State Space of Interest

Note: States include (1) being healthy (H), (2) being diabetic (D), (3) having at least one chronic condition (C), (4) having at least one ADL disability (A), (5) being diabetic with at least one condition (DC), (6) being diabetic with at least one ADL disability (DA), (7) having at least one condition and one ADL disability (CA), (8) being diabetic with a at least one condition and at least one ADL disability (DCA), and (9) death. Death is not shown but is allowed from all states. Retention is not shown but is allowed. The parenthetical numbers next to each state indicate how many transitions are possible from the given state.

Our main predictor of interest of these transitions is region of birth and region of residence at time of interview. We measure U.S. region in 4 categories: northeast, Midwest, south, and west.22 Currently, there is no consensus about which geographic level (region, division, etc.) to use to track health inequalities.23 While regional analyses may mask heterogeneity across states/counties, such analyses minimize issues associated with classifying individuals who live/work in different states/counties and migration effects (individuals are half as likely to move between regions as between states in any given year24).

Additional covariates included are age (years), sex (male=1), race (dummy variables for black and other race; white=reference), ethnicity (Hispanic=1), marital status (married=1), years of schooling, and birth cohort (birth year minus 1900). See Table 1 for descriptive statistics.

Table 1:

Descriptive statistics for covariates

Variable Mean(s.d)[range] or Percent
Birth Cohort 35.3(11.7)[−8,59]
Age 69.4(10.7)[50.2,109.7]
Male 44.4%
Race
White (reference) 79.0%
Black 18.0%
Other Race 3.0%
Hispanic 4.6%
Education 12.5(3.0)[0,17]
Married 52.1%
Birth Region
South (reference) 40.3%
Northeast 20.7%
Midwest 30.0%
West 9.0%
Current Region
South (reference) 41.4%
Northeast 15.3%
Midwest 26.1%
West 17.2%

Note: Data come from 1998–2014 waves of the Health and Retirement Survey. Descriptive statistics include all n = 80,146 transition intervals. Cohort is computed as birth year-1900.

Analysis

We adopt a Bayesian approach to produce multistate life tables (MSLT) and calculate regional disparities in LEs at age 50 between diabetic and healthy populations.25 The method involves: (1) sampling parameters from a multinomial logit model predicting transitions with the covariates above, using Markov chain Monte Carlo methods (Gibbs sampling); (2) generating sets of age-specific transition probability matrices from the samples by applying the sampled model coefficients to a selected set of covariate values; (3) applying standard MSLT calculations to the sets of transition probability matrices; and (4) summarizing quantities of interest from the tables.

Our approach to generating MSLTs is a recent extension of the Bayesian method developed by Lynch and Brown (2005), which uses Gibbs sampling to obtain parameter samples from a bivariate probit model for generating MSLTs for a very limited state space.26 Since our state space is of much higher dimensionality, we use a newly developed Gibbs sampler that can handle high dimensionality.27 We ran the Gibbs sampler twice, using randomly generated starting values and drew 2500 samples per run. The first 500 samples from each run were dropped as burn-in. Among the remaining 2000 samples from each chain, we kept every 4th draw to reduce autocorrelation in the samples, leaving 1000 posterior samples in total.28

Using each of the 1000 posterior samples, we calculated the 9-by-9 transition probability matrix at each even-number age from 50–110. We chose 50 as the starting age because diabetes prevalence is still low at this age.29 We constructed life tables (LTs) for populations defined by each combination of birth and current regions. All other covariates were set to their sample means, thereby controlling on regional differences in composition of these covariates. Finally, we calculated interval estimates for LEs from the collection of 1000 LTs for each birth/current region combination. All analyses were conducted using R.

We conducted 3 sets of analyses. First, to assess regional disparities in LEs for diabetic and healthy adults, we estimated total LE from diabetic and healthy status-based LTs by birth-current region combination. In diabetic status-based LTs, the radix is set so that all synthetic cohort members are diabetic at age 50 (but without chronic conditions or ADLs). The radix for healthy-based LTs is set so that all synthetic cohort members are healthy at age 50. Total LEs were calculated by summing LEs across all living states. Second, to examine the QoL among PWD, we estimated %XLE using diabetic status-based LTs. Individuals can acquire ADLs from diabetes without having other chronic conditions (e.g., one can have diabetic neuropathy that manifests as an ADL without having a direct heart disease diagnosis), or they can have other chronic conditions without having ADLs. Research documents an inverse relationship between multimorbidity and QoL,30,31 so we consider having other chronic conditions or ADLs as reducing QoL. This QoL measure, %XLE, is calculated by the number of years spent with only diabetes (XLE) divided by TLE in the diabetic status-based LTs. Posterior means are reported with 84% credible intervals, following the precedent of the frequentist literature showing that under the assumption of roughly equal standard errors, comparing multiple 84% intervals gives comparable results with a 5% level test.32 Finally, to summarize our findings on regional disparities, we estimate the probabilities that 1 region is worse than other regions in health outcomes. We consider the following health outcomes: TLE, XLE, life expectancy with diabetes and chronic conditions (XCLE), life expectancy with diabetes and ADLs (XDLE), life expectancy with all three health issues (XCDLE), as well as the proportions of these LEs with regard to TLE.

RESULTS

Figure 2 compares LEs at age 50 for diabetic and healthy individuals, with 84% credible intervals (see Online Appendix Tables 12 for full results of regional disparities in LEs for diabetic/healthy populations). The mean LEs for PWD range from 21.5–24.6 years, whereas means for the healthy population range from 30.4–32.3 years (gap of 5.8–10.8 years). Comparing across regions, PWD currently living in the south live shorter lives, on average: among the 5 birth-current region combinations with the shortest mean LEs, 4 involve current southern residence. Currently living in the south is similarly adverse for those who are healthy at age 50: among the 5 birth-current region combinations with the shortest mean LEs, 4 involve current southern residence. In particular, persons born in the south or northeast and currently living in the south tend to have the shortest LEs (estimated probability of 96%).

Figure 2:

Figure 2:

Regional Differences in Life Expectancies at Age 50 by Diabetes Status, with 84% Credible Intervals

Note: Regions include west (W), south (S), northeast (NE), and midwest (MW).

To examine HE across region, we calculated %XLE for PWD at age 50 (Figure 3). On average, people born in the south have the smallest proportions of life remaining without either other chronic conditions or ADLs. Among the 5 birth-current region combinations that have the smallest means, 4 involve southern birth.

Figure 3:

Figure 3:

Regional Differences in Proportions of Life Remaining Without Either Chronic Conditions or ADLs at Age 50 among Diabetic Population, with 84% Credible Intervals

Note: Regions include west (W), south (S), northeast (NE), and midwest (MW).

These results suggest that currently residing in the south is linked to shorter LEs for individuals with or without diabetes and southern birth is linked to lower QoL for PWD. To quantify these disparities, we estimate the posterior probabilities that southern health outcomes are worse than those of other regions from diabetes status-based LTs (Table 2). Three findings are particularly noteworthy. First, the probabilities of developing other chronic conditions and ADLs and spending greater proportions of life with these diseases for PWD born in the south versus other regions are at least 80%. Second, the probabilities of not having either other chronic conditions or ADLs and spending greater proportions of life without chronic conditions or ADLs for southern-born PWD are at least 70%. Third, the probabilities of having a shorter LE for PWD currently living in the south are 79.2% compared to the northeast, 93.4% compared to the Midwest, and 66.2% compared to the west.

Table 2:

Estimated probabilities that health outcomes of southerners are worse compared to those from other regions

Birth Region Current Region
Measure NE MW W NE MW W
TLE (<) 0.356 0.599 0.618 0.792 0.934 0.662
XLE (<) 0.748 0.877 0.704 0.703 0.739 0.363
XCLE 0.794 0.629 0.543 0.517 0.156 0.301
XDLE 0.583 0.654 0.259 0.083 0.184 0.486
XCDLE 0.879 0.924 0.808 0.521 0.270 0.098
%XLE (<) 0.899 0.922 0.699 0.545 0.358 0.202
%XCLE 0.766 0.676 0.612 0.701 0.400 0.375
%XDLE 0.544 0.687 0.273 0.109 0.312 0.543
%XCDLE 0.860 0.947 0.851 0.671 0.553 0.141

Note: Probabilities are estimated from diabetic status-based life tables. Regions include west (W), south (S), northeast (NE), Midwest (MW). Life expectancies include total life expectancy (TLE), life expectancy with only diabetes (XLE), life expectancy with diabetes and chronic conditions (XCLE), life expectancy with diabetes and ADLs (XDLE), life expectancy with all three health issues (XCDLE). %XLE etc. are calculated using XLE etc. divided by TLE. “Worse” means shorter total life expectancy, shorter life expectancy with only diabetes, longer life expectancy with more than one disease, etc.

DISCUSSION

Comparing LEs between diabetic and healthy populations can elucidate the impact of diabetes on population health. We hypothesized that diabetes would be associated with shorter LEs across all U.S. regions and that southern birth/current region would be associated with shorter LEs and more time spent with chronic conditions/ADLs for PWD. Consistent with our first hypothesis, estimates showed that, at age 50, PWD could expect to live, on average, 5.8–10.8 years less than their healthy equivalents. These numbers are consistent with those estimated from the Framingham Heart Study, with the gaps equal to 8.2 (7.5) years for men (women).33

While the increased mortality associated with diabetes is well-documented, a novel contribution of our study is the regional differences in LEs among PWD. Previous research in the U.S. reveals that diabetes is more prevalent in the south,10 which our study confirmed. In terms of HE, research from the U.K. has shown that men (women) without diabetes at age 65 had 4.1 (5.1) years free of ADLs and instrumental ADLs compared to those with diabetes.34 Consistent with our second hypothesis, diabetes had the greatest influence on both LE and HE for older adults who were born in or currently lived in the south. As such, southerners with diabetes not only have a reduced LE but also spend more time living with disability or other chronic conditions. Moreover, it is important to distinguish between those of southern birth versus those currently residing in the south. On the one hand, diabetes is influenced by cultural, behavioral, and environmental factors, so southern-born individuals may experience factors that influence their awareness of their diabetic status or need for treatment,35 thus resulting in the worst QoL compared to other regions. On the other hand, people living in the south are less likely to access medical care36 or have health insurance,37 which may contribute to shorter LEs if southerners do not seek treatment for diabetes.

Limitations

First, because of the complexity of directly adjusting for the HRS’ complex sampling design in Bayesian models, we adopted a recommended approach to account for sample clustering and weighting.38 Specifically, we controlled for race/ethnicity and region in our regression models, which accounts for the probability of inclusion and nonresponse due to these factors and helps with the potential consequences of not using HRS sample weights. In addition, compared to other studies using data from a cohort with a long follow-up period (e.g., Framingham Heart Study), our sample is more nationally representative because considerable numbers of blacks and Hispanics are included. Since minorities have a higher risk of diabetes, ignoring them could underestimate the true public health burden of diabetes. Indeed, our analyses produced LE estimates that are consistent with national estimates, and our large sample size reduces the potential bias in standard errors.

Second, due to data limitations, a common assumption made by most existing MSLT methods is that the data are complete and only 1 net transition can happen between successive observations for each individual. This assumption is met when either a single transition between intervals that occurs at the midpoint or possibly repeated transitions between the starting and ending state that balance out to yield half the time in each state based on the linear assumption. Older adults are likely to experience fast chronic disease accumulation and multimorbidity development. Therefore, when the assumption is not met, our 2-year intervals could miss certain transitions. For example, PWD can develop ADLs shortly before death so that multiple transitions (i.e. from D to DA and from DA to dead) happen in 1 interval. In this case, %XLE at age 50 can be overestimated. However, because our focus is regional disparities, and it is plausible that this kind of situations have equal chances to happen across regions, our substantive conclusion on regional disparities should still hold.

Third, selective mortality before age 50 may lead to a higher probability of healthier individuals (e.g. whites, people not living in the south) being included in the survey. In our model, we adjust for major factors that may affect mid-life mortality (e.g., birth cohort, educational attainment, race/ethnicity, marital status). Additionally, our analyses are descriptive and forecasting in nature rather than causal. The population of interest is the older population, which by default is conditional on living to age 50.

Finally, LT results are based on a hypothetical cohort: showing what would happen to a cohort if it were subjected for all of its life to the mortality conditions of the period covered. If there are dramatic changes after 2014, readers should be cautious when generalizing this study’s results.

Public Health Implications

Our results confirm that diabetes is a major U.S. public health concern and show that the burden of diabetes varies by region of birth and current residence. On average, diabetes reduces LE by 5.8–10.8 years across regions. This is problematic because diabetes is often accompanied by chronic conditions and disabilities, which can impact both independent functioning and QoL.13,14 Moreover, these numbers mean a significant burden to the U.S. medical system during PWDs’ dependent years,39 and the burden will not be the same to local medical systems across regions. Future studies should monitor the gap in LEs between diabetic and healthy populations.

The regional variations we identified are consistent with previous research indicating that diabetes is particularly prevalent in the south.10,11 These geographic patterns could be due to multiple factors, including regional differences in socioeconomic conditions and diabetes care; region-specific programs and policies; and regional, cultural, and behavioral factors. Public policies are needed to develop targeted interventions to narrow the geographic inequality in the impact of diabetes on population health. Policies targeting both early-life interventions for southern-born individuals and care for older adults living in the south are needed. To that end, estimates from this study can be used to inform public health initiatives and to help guide diabetes-related policies.

STATEMENTS

License for Publication: The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive license (or non-exclusive for government employees) on a worldwide basis to the BMJ Publishing Group Ltd to permit this article (if accepted) to be published in JECH and any other BMJPGL products and sublicences such use and exploit all subsidiary rights, as set out in our license (http://group.bmj.com/products/journals/instructions-for-authors/licence-forms).

Supplementary Material

Appendix Tables

SUMMARY BOX.

What is already known on this subject?

Previous research has demonstrated large disparities in life expectancies between populations with and without diabetes in the U.S. Despite evidence that diabetes is more prevalent in the south, little work has been done to consider the roles of birth and current regions jointly in these life expectancy disparities.

What does this study add?

At age 50, persons with diabetes were expected to live on average 5.8–10.8 years less than their healthy equivalents across regions. Diabetes had the greatest influence on life expectancy for older adults who lived in the south at the time of interview. Persons with diabetes born in the south were more likely to have a lower quality of life.

Acknowledgement

Dr. Zang received support from the Research Education Core of the Claude D. Pepper Older Americans Independence Center at Yale School of Medicine (P30AG021342). Dr. Lynch received support from NIH/NIA grant R01AG040199. We thank Matthew van Adelsberg, Justin T. Max, and Seth G. Sanders for their helpful comments.

Footnotes

Competing Interest: None declared.

REFERENCES

  • 1.Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and Trends in Diabetes Among Adults in the United States, 1988–2012. Jama. 2015;314(10):1021–1029. [DOI] [PubMed] [Google Scholar]
  • 2.Centers for Disease Control and Prevention. National Diabetes Statistics Report. Atlanta, GA: 2017. [Google Scholar]
  • 3.Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352(11):1138–1145. [DOI] [PubMed] [Google Scholar]
  • 4.Preston SH, Stokes A. Contribution of Obesity to International Differences in Life Expectancy. American Journal of Public Health. 2011;101(11):2137–2143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Laditka SB, Laditka JN. Active life expectancy of Americans with diabetes: risks of heart disease, obesity, and inactivity. Diabetes Res Clin Pract. 2015;107(1):37–45. [DOI] [PubMed] [Google Scholar]
  • 6.Preston SH, Choi D, Elo IT, Stokes A. Effect of diabetes on life expectancy in the United States by race and ethnicity. Biodemography and social biology. 2018;64(2):139–151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Arias E, Heron M, Tejada-Vera B. United States life tables eliminating certain causes of death, 1999–2001. Natl Vital Stat Rep. 2013;61(9):1–128. [PubMed] [Google Scholar]
  • 8.Borhani NO. Changes and Geographic Distribution of Mortality from Cerebrovascular Disease. American journal of public health. 1965;55(5):673–681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Liao Y, Greenlund KJ, Croft JB, Keenan NL, Giles WH. Factors explaining excess stroke prevalence in the US Stroke Belt. Stroke. 2009;40(10):3336–3341. [DOI] [PubMed] [Google Scholar]
  • 10.Barker LE, Kirtland KA, Gregg EW, Geiss LS, Thompson TJ. Geographic distribution of diagnosed diabetes in the U.S.: a diabetes belt. Am J Prev Med. 2011;40(4):434–439. [DOI] [PubMed] [Google Scholar]
  • 11.Danaei G, Friedman AB, Oza S, Murray CJL, Ezzati M. Diabetes prevalence and diagnosis in US states: analysis of health surveys. Population Health Metrics. 2009;7(1):16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Saito Y, Robine J-M, Crimmins EM. The methods and materials of health expectancy. Stat J IAOS. 2014;30(3):209–223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Piette JD, Kerr EA. The Impact of Comorbid Chronic Conditions on Diabetes Care. Diabetes Care. 2006;29(3):725. [DOI] [PubMed] [Google Scholar]
  • 14.Gregg EW, Mangione CM, Cauley JA, et al. Diabetes and incidence of functional disability in older women. Diabetes Care. 2002;25(1):61–67. [DOI] [PubMed] [Google Scholar]
  • 15.RAND Center for the Study of Aging. RAND HRS Data. In: RAND Center for the Study of Aging, ed. Santa Monica, CA: 2019. [Google Scholar]
  • 16.Ehrlich SF, Quesenberry CP Jr., Van Den Eeden SK, Shan J, Ferrara A. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care. 2010;33(1):55–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and Cancer: A Consensus Report. CA: A Cancer Journal for Clinicians. 2010;60(4):207–221. [DOI] [PubMed] [Google Scholar]
  • 18.Gregg EW, Li Y, Wang J, et al. Changes in Diabetes-Related Complications in the United States, 1990–2010. New England Journal of Medicine. 2014;370(16):1514–1523. [DOI] [PubMed] [Google Scholar]
  • 19.Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The Incidence of Congestive Heart Failure in Type 2 Diabetes. An update. 2004;27(8):1879–1884. [DOI] [PubMed] [Google Scholar]
  • 20.Rawshani A, Rawshani A, Franzén S, et al. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. New England Journal of Medicine. 2017;376(15):1407–1418. [DOI] [PubMed] [Google Scholar]
  • 21.Wojciechowska J, Krajewski W, Bolanowski M, Kręcicki T, Zatoński T. Diabetes and Cancer: a Review of Current Knowledge. Exp Clin Endocrinol Diabetes. 2016;124(5):263–275. [DOI] [PubMed] [Google Scholar]
  • 22.U.S. Census Bureau. Statistical Groupings of States and Counties. 2018.
  • 23.Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. Am J Epidemiol. 2002;156(5):471–482. [DOI] [PubMed] [Google Scholar]
  • 24.DeAre DR. Geographical Mobility: March 1990 to March 1991. U.S. Bureau of the Census, Current Population Reports, Washington, DC: U.S. Government Printing Office; 1992. [Google Scholar]
  • 25.Zang E, Lynch SM. Bayesian multistate life table methods for complex, high-dimensional state spaces: Development and illustration of a new method. Population Association of America; 2018; Denver, CO. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Lynch SM, Brown JS. A New Approach to Estimating Life Tables with Covariates and Constructing Interval Estimates of Life Table Quantities. Sociological Methodology. 2005;35(1):177–225. [Google Scholar]
  • 27.Polson NG, Scott JG, Windle J. Bayesian inference for logistic models using Pólya–Gamma latent variables. Journal of the American Statistical Association. 2013;108(504):1339–1349. [Google Scholar]
  • 28.Gilks W, Richardson S, Spiegelhalter D. Markov Chain Monte Carlo in Practice. Chapman and Hall/CRC; 1995. [Google Scholar]
  • 29.Jonker JT, De Laet C, Franco OH, Peeters A, Mackenbach J, Nusselder WJ. Physical activity and life expectancy with and without diabetes: life table analysis of the Framingham Heart Study. Diabetes Care. 2006;29(1):38–43. [DOI] [PubMed] [Google Scholar]
  • 30.Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D. Multimorbidity and quality of life in primary care: a systematic review. Health and quality of life outcomes. 2004;2:51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Makovski TT, Schmitz S, Zeegers MP, Stranges S, van den Akker M. Multimorbidity and quality of life: Systematic literature review and meta-analysis. Ageing Research Reviews. 2019;53:100903. [DOI] [PubMed] [Google Scholar]
  • 32.Payton ME, Greenstone MH, Schenker N. Overlapping confidence intervals or standard error intervals: what do they mean in terms of statistical significance? J Insect Sci. 2003;3:34–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med. 2007;167(11):1145–1151. [DOI] [PubMed] [Google Scholar]
  • 34.Jagger C, Matthews R, Matthews F, et al. The Burden of Diseases on Disability-Free Life Expectancy in Later Life. The journals of gerontology. Series A, Biological sciences and medical sciences. 2007;62(4):408–414. [DOI] [PubMed] [Google Scholar]
  • 35.Menke A, Casagrande S, Aviles-Santa ML, Cowie CC. Factors Associated With Being Unaware of Having Diabetes. Diabetes Care. Vol 40. United States2017:e55–e56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Lanska DJ, Kryscio R. Geographic distribution of hospitalization rates, case fatality, and mortality from stroke in the United States. Neurology. 1994;44(8):1541–1550. [DOI] [PubMed] [Google Scholar]
  • 37.Barnett JC, Vornovitsky MS. Health Insurance Coverage in the United States: 2015. Current Population Reports, P60–257(RV), U.S. Government Printing Office, Washington, D.C.2016. [Google Scholar]
  • 38.Gelman A Struggles with Survey Weighting and Regression Modeling. Statist. Sci. 2007;22(2):153–164. [Google Scholar]
  • 39.American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care. 2018:dci180007. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Appendix Tables

RESOURCES